Derivation, validation, and potential treatment implications of novel clinical phenotypes for sepsis CW Seymour, JN Kennedy, S Wang, CCH Chang, CF Elliott, Z Xu, S Berry, ... Jama 321 (20), 2003-2017, 2019 | 1141 | 2019 |
Proportion and Cost of Unplanned 30-Day Readmissions After Sepsis Compared With Other Medical Conditions FB Mayr, VB Talisa, V Balakumar, CCH Chang, M Fine, S Yende JAMA, 2017 | 180 | 2017 |
Long-term host immune response trajectories among hospitalized patients with sepsis S Yende, JA Kellum, VB Talisa, OMP Palmer, CCH Chang, MR Filbin, ... JAMA network open 2 (8), e198686-e198686, 2019 | 146 | 2019 |
Sepsis Subclasses: A Framework for Development and Interpretation. KM DeMerle, DC Angus, JK Baillie, E Brant, CS Calfee, J Carcillo, ... Critical care medicine, 2021 | 133 | 2021 |
Exercise, manual therapy, and use of booster sessions in physical therapy for knee osteoarthritis: a multi-center, factorial randomized clinical trial GK Fitzgerald, JM Fritz, JD Childs, GP Brennan, V Talisa, AB Gil, ... Osteoarthritis and cartilage 24 (8), 1340-1349, 2016 | 93 | 2016 |
Children with chronic disease bear the highest burden of pediatric sepsis AJ Prout, VB Talisa, JA Carcillo, FB Mayr, DC Angus, CW Seymour, ... The Journal of pediatrics 199, 194-199. e1, 2018 | 73 | 2018 |
Effectiveness of homologous or heterologous Covid-19 boosters in veterans FB Mayr, VB Talisa, O Shaikh, S Yende, AA Butt New England Journal of Medicine 386 (14), 1375-1377, 2022 | 70 | 2022 |
Autism and anxiety in males with fragile X syndrome: An exploratory analysis of neurobehavioral profiles from a parent survey VB Talisa, L Boyle, D Crafa, WE Kaufmann American Journal of Medical Genetics Part A 164 (5), 1198-1203, 2014 | 70 | 2014 |
Parental reports on early language and motor milestones in fragile X syndrome with and without autism spectrum disorders R Hinton, DB Budimirovic, PB Marschik, VB Talisa, C Einspieler, T Gipson, ... Developmental neurorehabilitation 16 (1), 58-66, 2013 | 54 | 2013 |
Arguing for adaptive clinical trials in sepsis VB Talisa, S Yende, CW Seymour, DC Angus Frontiers in immunology 9, 1502, 2018 | 46 | 2018 |
COVID-19 disease severity in US Veterans infected during Omicron and Delta variant predominant periods FB Mayr, VB Talisa, AD Castro, OS Shaikh, SB Omer, AA Butt Nature communications 13 (1), 1-6, 2022 | 42 | 2022 |
Intra-uterine exposure to maternal opiate abuse and HIV: The impact on the developing nervous system AB Palchik, C Einspieler, IV Evstafeyeva, VB Talisa, PB Marschik Early human development 89 (4), 229-235, 2013 | 36 | 2013 |
Peculiarities in the gestural repertoire: An early marker for Rett syndrome? PB Marschik, J Sigafoos, WE Kaufmann, T Wolin, VB Talisa, ... Research in developmental disabilities 33 (6), 1715-1721, 2012 | 32 | 2012 |
Estimating the Impact of Necrotizing Soft Tissue Infections in the United States: Incidence and Re-Admissions AK May, VB Talisa, DA Wilfret, E Bulger, W Dankner, A Bernard, S Yende Surgical Infections, 2020 | 29 | 2020 |
Relative vaccine effectiveness of a SARS-CoV-2 mRNA vaccine booster dose against the Omicron variant. AA Butt, VB Talisa, OS Shaikh, SB Omer, FB Mayr Clinical Infectious Diseases: an Official Publication of the Infectious …, 2022 | 28 | 2022 |
Bacterial and Fungal Etiology of Sepsis in Children in the United States: Reconsidering Empiric Therapy AJ Prout, VB Talisa, JA Carcillo, BK Decker, S Yende Critical Care Medicine, 2020 | 27 | 2020 |
Relative vaccine effectiveness of a severe acute respiratory syndrome coronavirus 2 messenger RNA vaccine booster dose against the Omicron variant AA Butt, VB Talisa, OS Shaikh, SB Omer, FB Mayr Clinical Infectious Diseases, 2022 | 25 | 2022 |
Epidemiology of readmissions after sepsis hospitalization in children AJ Prout, VB Talisa, JA Carcillo, DC Angus, CCH Chang, S Yende Hospital pediatrics 9 (4), 249-255, 2019 | 20 | 2019 |
Comparative COVID-19 Vaccine Effectiveness Over Time in Veterans FB Mayr, VB Talisa, OS Shaikh, SB Omer, AA Butt, S Yende Open forum infectious diseases 9 (7), ofac311, 2022 | 16 | 2022 |
Vaccine Effectiveness of 3 Versus 2 Doses of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) mRNA Vaccines in a High-Risk National Population AA Butt, VB Talisa, P Yan, OS Shaikh, SB Omer, FB Mayr Clinical Infectious Diseases, 2022 | 15 | 2022 |